Literature DB >> 9541370

A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts.

R V Gibbons1, F J Landry, D L Blouch, D L Jones, F K Williams, C R Lucey, K Kroenke.   

Abstract

OBJECTIVE: To compare physicians' and their patients' attitudes toward pharmaceutical gifts.
DESIGN: Survey of physicians and their patients.
SETTING: Two tertiary-care medical centers, one military and one civilian. PARTICIPANTS: Two hundred sixty-eight of 392 consecutively surveyed physicians, 100 of 103 randomly selected patients at the military center, and 96 patients in a convenience sample at the civilian center completed the survey. MEASUREMENTS: Participants rated 10 pharmaceutical gifts on whether they were appropriate for physicians to accept and whether they were likely to influence prescribing. Patients found gifts less appropriate and more influential than did their physicians. About half of the patients were aware of such gifts; of those unaware, 24% responded that this knowledge altered their perception of the medical profession. Asked whether they thought their own physician accepted gifts, 27% said yes, 20% no, and 53% were unsure. For patients, feeling that gifts were inappropriate was best predicted by a belief that gifts might influence prescribing, while for physicians, the best predictor was knowledge of guidelines.
CONCLUSIONS: Patients feel pharmaceutical gifts are more influential and less appropriate than do their physicians. Physicians may want to consider this in deciding whether to accept particular gifts. Broader dissemination of guidelines may be one means of changing physician behavior. At the same time, future guidelines should further consider the potentially different viewpoints of patients and physicians.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  1998        PMID: 9541370      PMCID: PMC1496923          DOI: 10.1046/j.1525-1497.1998.00048.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  14 in total

1.  Pharmaceutical promotions--a free lunch?

Authors:  D R Waud
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

2.  Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors.

Authors:  P R Lichstein; R C Turner; K O'Brien
Journal:  Arch Intern Med       Date:  1992-05

3.  Gifts to physicians from industry.

Authors: 
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

4.  Kennedy hearings say no more free lunch--or much else--from drug firms.

Authors:  T Randall
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

5.  The ethics of accepting gifts from pharmaceutical companies.

Authors:  L H Margolis
Journal:  Pediatrics       Date:  1991-12       Impact factor: 7.124

6.  Why do American drug companies spend more than $12 billion a year pushing drugs? Is it education or promotion? Characteristics of materials distributed by drug companies: four points of view.

Authors:  S M Wolfe
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

7.  Physicians and the pharmaceutical industry. American College of Physicians.

Authors: 
Journal:  Ann Intern Med       Date:  1990-04-15       Impact factor: 25.391

8.  Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.

Authors:  N Lurie; E C Rich; D E Simpson; J Meyer; D L Schiedermayer; J L Goodman; W P McKinney
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

9.  Doctors, drug companies, and gifts.

Authors:  M M Chren; C S Landefeld; T H Murray
Journal:  JAMA       Date:  1989 Dec 22-29       Impact factor: 56.272

10.  Pharmaceutical representatives and emergency medicine residents: a national survey.

Authors:  M Reeder; J Dougherty; L J White
Journal:  Ann Emerg Med       Date:  1993-10       Impact factor: 5.721

View more
  31 in total

1.  Pharmaceutical advertising revenue and physician organizations: how much is too much?

Authors:  P A Glassman; J Hunter-Hayes; T Nakamura
Journal:  West J Med       Date:  1999-10

2.  [Psychiatrists and the pharmaceutical industry].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

Review 3.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

4.  Bias in research and conflict of interest: why should we care?

Authors:  H P Dietz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-21

5.  Interactions of doctors with the pharmaceutical industry.

Authors:  M A Morgan; J Dana; G Loewenstein; S Zinberg; J Schulkin
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

6.  Of porcupines and poodles--a joint challenge to industry and the profession.

Authors:  Paul Hilton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-10-06

7.  The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab.

Authors:  Jathin Bandari; Robert M Turner; Bruce L Jacobs; David Canes; Ali Moinzadeh; Benjamin J Davies
Journal:  Urol Pract       Date:  2017-01

Review 8.  Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention?

Authors:  David Grande
Journal:  J Gen Intern Med       Date:  2009-09-12       Impact factor: 5.128

Review 9.  Bioethics for clinicians: 17. Conflict of interest in research, education and patient care.

Authors:  T Lemmens; P A Singer
Journal:  CMAJ       Date:  1998-10-20       Impact factor: 8.262

10.  Patients' beliefs and preferences regarding doctors' medication recommendations.

Authors:  Sarah L Goff; Kathleen M Mazor; Vanessa Meterko; Katherine Dodd; James Sabin
Journal:  J Gen Intern Med       Date:  2008-01-18       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.